{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"catastrophic-antiphospholipid","columns":[{"gene":"","key":"population-2b47a42402f9d53ce9d7","label":"Catastrophic antiphospholipid syndrome","mondoId":"MONDO:0018737","onsetQualifier":null,"originColumnKey":"MONDO:0018737/ORPHA:464343","originalViews":[{"key":"MONDO:0018737/ORPHA:464343","label":"Catastrophic antiphospholipid syndrome","scopeLabel":"ORPHA:464343","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["05b927f28e1415ccafde427ea776ba163d2a06c540f3e2df85e0d5572fb8fec0","05c785a736abf69a759ee6b11a1007b6c6e2cca7f037fb99f327c75e6ebbb484","08a294aefdd5c08bdc7b486b18ecbfdf1e32cfd0ddb08bf9020e32d8e0ddd6a0","0ed8c787caf4142d23fc313de3fa34fd8b9cd1c95f835f13986736b11628418a","11eb11d361f8ffe7a0de914beb700ff9afe6712cb3b1c688656228986276c660","18b31042633b2fd9bd193541150f16d628aaf3b9a86cab1c12323e500d3335d9","225f08bcef524c4e541ebf8ef584210f284b2507605182b86c7ff6fed6da2a12","283c697a68105336b17018ba1192e932b8729540837f383b25fc3bde03656d87","2a29d0512c686ecc51a71519381f895e320b6b45a97c218c7974fd590ba9dad3","305d15a70c5ef89355f844071490f50769987e3071f9ce21d22446efbf7d3977","3727dc432c667b24d44b31d61e1d98b63245730b7c6a75eb73a19fd2b4a7abdd","43e1b2c115a7f224f4a4f5c436b8981e231b3331fc589a1da6365abe31bfc592","46c71b7e07a2806578bab8166f35deca793ec5cf504dd1a1a38046f94d2e2485","4d3150ac35c5211964a669e0e2126d58db86481ab469dced97b1eb9d4224eee2","504207367de964181bf31dedf7b99f9dade27240ca8673f6a8b02f2904de21fd","522ea893cace600ae9309a7b60b232707d7b1daaccd8fb595aa5aa37dca1ebb1","5442f461ac0a7caa30e130beacdd8805c653d9da5a0263c7244afa9e0bbb5467","5556723b5d06b0f233a0f96b2642df9b652cc6a4b7eb0f78a16160cac1f714f4","5ba939de4f33717e9f6dc55b6149df2f584cc0b99169b71a0428c04df9528e2b","60d3a89acaf63107afcd2469f02fc54e2d5e267db94a6cfa8b19dec2ea8e1122","680d82575f7475c0fd581f8a1aaff052d98c91cefcf6f0a96a70e258d37eec2f","701f5f6893cab8037817484e62ed392a1a9d4a1698e84bec481f3b0e74f6b168","789377788c8d20dd3b40b329e776627651d840706b2ef0490e84f617405eda8c","906a89df2604c322f8b068399404fbf91a15471e246e373bde0d17aa3f00135b","9f7673fac51bf4749a8efd64ade11f3488579769cc3e4f7fa029ba771d4d3e0f","a03bcacef923d748df04c7977ada38ca428a67d5dba24ee411b1e0fe1753410d","a2c1d6f492fa1541ba857803d4e376a096d0f23a7497e1cb155883ef02fa5a33","a4f3e588d6cba0d81500875aa1d4a7d670466a82c974769829b708ee741a43ee","a9d3899033e7ae92496b2faefedf139c86e0f62d4378fecea9b6f1bdd5a29f92","b881ae971fc780685e0544a904e9ab2ff3e04de729dd52ee7250e73f78ccab7f","bae367b7c72ce1e06be068e2f22bc265a562712c26468d5237627ce0340511ab","bcee1701ee81c9d78cf4b297cc6ab09a36e4fc5972b2a6eec099efe41c7115ff","bff21dbfba9b691ab65b43298db462f1dba0a12d03052d517c3a88e05164236d","c24fa480d710f257c3d90b128a618e071070fa01d1397fa670714ee7db4100a5","c3dcc39f2c476ae52c7b01dc105a8b144e13ddd468a4d529841731f71fe196a9","c772651f688cc5000459659e06d0340943bd84b7d25d6d47114d3399a347804a","c9f1499bfcb635eead7b098888f9f6f021e9b36d1293244767d3a682f483cd7e","cd453599b6dc819b82c5e26db8acf470f074ff8a138e79189c1337fee8b1a034","ce9bfbd9d0a46996e1352907d4173e52d09dfac1ccb6490ea98ea442a22fa74d","dd182683b3dc33bb4a22e6ef95ce17cddc79d523e54ac10787ffebeeeff5f26e","dd40f356faaad82fd0ee763ebf32e0fcc7aeaafc2eb8d0203582cda2bba0bbf7","ddc09f4e8edc2073085f5f42c4e77da9eec736cd08035c5688f5bc1ecd703ac3","eb1b8a15eafbb9ee65d6edef61ddfddf8b344b22862344bb85253f4028eec99a","ecd8cce8e8802d5d5b97e75007876d46920bdd059efdb23f351341f5c810612c","f872f9aae28fc7ec2882c6b427417767828dee713cd374131155d451dc70e3c5","f8821c962e2cadce4450f184ee25a8baed1d46b0056c04242bd03616c9235de8","fcaed1d25322aa6bf2da61fa97ba6ffd4d3460062e82c98e4acaf502a4a7c793","fe3011f4464e5625eaa9855587a8a32bace175043a074d9ae98c66575aa1d12b","ff9642381671e05b3e0a40e01952e3a9db7bc710cb6ef49f9734dbf7ccdb66fa"],"recordQualifiers":{},"scopeLabel":"ORPHA:464343","sourceIds":["ORPHA:464343"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-2b47a42402f9d53ce9d7"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0011112","HP:0001654","HP:0031653","HP:3000042","HP:0001977","HP:0000077","HP:0000707"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":49,"sourceGroups":{"orphanet":49}},"features":[{"hpoId":"HP:0011112","label":"Abnormal circulating cytokine concentration","primary":true},{"hpoId":"HP:0001654","label":"Abnormal heart valve morphology","primary":true},{"hpoId":"HP:0031653","label":"Abnormal heart valve physiology","primary":true},{"hpoId":"HP:3000042","label":"Abnormal jugular vein morphology","primary":true},{"hpoId":"HP:0001977","label":"Abnormal thrombosis","primary":true},{"hpoId":"HP:0000077","label":"Abnormality of the kidney","primary":true},{"hpoId":"HP:0000707","label":"Abnormality of the nervous system","primary":true},{"hpoId":"HP:0006846","label":"Acute encephalopathy","primary":false},{"hpoId":"HP:0100576","label":"Amaurosis fugax","primary":false},{"hpoId":"HP:0001681","label":"Angina pectoris","primary":false},{"hpoId":"HP:0034101","label":"Anti-annexin-V antibody positivity","primary":false},{"hpoId":"HP:0032376","label":"Anti-beta 2 glycoprotein I antibody positivity","primary":false},{"hpoId":"HP:0034097","label":"Anti-phosphatidyl choline antibody positivity","primary":false},{"hpoId":"HP:0034084","label":"Anti-phosphatidyl ethanolamine antibody positivity","primary":false},{"hpoId":"HP:0034098","label":"Anti-phosphatidyl glycerol antibody positivity","primary":false},{"hpoId":"HP:0034099","label":"Anti-phosphatidyl inositol antibody positivity","primary":false},{"hpoId":"HP:0034100","label":"Anti-phosphatidyl serine antibody positivity","primary":false},{"hpoId":"HP:0020136","label":"Anticardiolipin IgG antibody positivity","primary":false},{"hpoId":"HP:0020137","label":"Anticardiolipin IgM antibody positivity","primary":false},{"hpoId":"HP:0003613","label":"Antiphospholipid antibody positivity","primary":false},{"hpoId":"HP:0025324","label":"Arterial occlusion","primary":false},{"hpoId":"HP:0004420","label":"Arterial thrombosis","primary":false},{"hpoId":"HP:0002829","label":"Arthralgia","primary":false},{"hpoId":"HP:0001369","label":"Arthritis","primary":false},{"hpoId":"HP:0010885","label":"Avascular necrosis","primary":false},{"hpoId":"HP:0002072","label":"Chorea","primary":false},{"hpoId":"HP:0004844","label":"Coombs-positive hemolytic anemia","primary":false},{"hpoId":"HP:0000965","label":"Cutis marmorata","primary":false},{"hpoId":"HP:0002625","label":"Deep venous thrombosis","primary":false},{"hpoId":"HP:0000726","label":"Dementia","primary":false},{"hpoId":"HP:0100758","label":"Gangrene","primary":false},{"hpoId":"HP:0005244","label":"Gastrointestinal infarctions","primary":false},{"hpoId":"HP:0025343","label":"Lupus anticoagulant","primary":false},{"hpoId":"HP:0001937","label":"Microangiopathic hemolytic anemia","primary":false},{"hpoId":"HP:0002076","label":"Migraine","primary":false},{"hpoId":"HP:0001658","label":"Myocardial infarction","primary":false},{"hpoId":"HP:0012819","label":"Myocarditis","primary":false},{"hpoId":"HP:0002641","label":"Peripheral thrombosis","primary":false},{"hpoId":"HP:0002092","label":"Pulmonary arterial hypertension","primary":false},{"hpoId":"HP:0002204","label":"Pulmonary embolism","primary":false},{"hpoId":"HP:0025326","label":"Retinal arterial occlusion","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0200042","label":"Skin ulcer","primary":false},{"hpoId":"HP:0001297","label":"Stroke","primary":false},{"hpoId":"HP:0002638","label":"Superficial thrombophlebitis","primary":false},{"hpoId":"HP:0002725","label":"Systemic lupus erythematosus","primary":false},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false},{"hpoId":"HP:0002326","label":"Transient ischemic attack","primary":false},{"hpoId":"HP:0004936","label":"Venous thrombosis","primary":false}],"ledeHtml":"A rare systemic autoimmune disease characterized by acute onset of life-threatening thromboses in three or more organs either simultaneously or within less than a week, in the presence of serum antiphospholipid antibodies (such as lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein 1 antibodies), and with histopathological confirmation of small-vessel occlusion in at least one affected organ. The condition is often precipitated by infection, trauma, or surgery.","mondoId":"MONDO:0018737","node":{"canonicalSlug":"catastrophic-antiphospholipid","comparisons":[{"documentSha256":"894f2d9aec17ac5625c6a9beb48f8f4dfdbfb0053b6c65ab16032df448f74d6c","key":"legacy-antiphospholipid","kind":"legacy","label":"antiphospholipid syndrome","memberIds":["MONDO:0018737","MONDO:8000010","MONDO:8000014"],"mondoId":"MONDO:8000010","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/antiphospholipid.894f2d9aec17ac5625c6a9beb48f8f4dfdbfb0053b6c65ab16032df448f74d6c.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Catastrophic antiphospholipid syndrome","originalSourceId":"ORPHA:464343","paragraphs":["A rare systemic autoimmune disease characterized by acute onset of life-threatening thromboses in three or more organs either simultaneously or within less than a week, in the presence of serum antiphospholipid antibodies (such as lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein 1 antibodies), and with histopathological confirmation of small-vessel occlusion in at least one affected organ. The condition is often precipitated by infection, trauma, or surgery."],"rawAttribution":"GARD:0009820","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:40:48Z","upstream":"GARD:0009820","url":"https://rarediseases.info.nih.gov/diseases/9820"},"ownColumnKeys":["population-2b47a42402f9d53ce9d7"],"publication":"published","relationships":[{"kind":"parent","label":"antiphospholipid syndrome","mondoId":"MONDO:8000010","slug":"antiphospholipid"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"range","key":"05b927f28e1415ccafde427ea776ba163d2a06c540f3e2df85e0d5572fb8fec0","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0025343","is_excluded":false,"label":"Lupus anticoagulant","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"05c785a736abf69a759ee6b11a1007b6c6e2cca7f037fb99f327c75e6ebbb484","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001977","is_excluded":false,"label":"Abnormal thrombosis","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"08a294aefdd5c08bdc7b486b18ecbfdf1e32cfd0ddb08bf9020e32d8e0ddd6a0","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000077","is_excluded":false,"label":"Abnormality of the kidney","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0ed8c787caf4142d23fc313de3fa34fd8b9cd1c95f835f13986736b11628418a","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002725","is_excluded":false,"label":"Systemic lupus erythematosus","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"11eb11d361f8ffe7a0de914beb700ff9afe6712cb3b1c688656228986276c660","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0034099","is_excluded":false,"label":"Anti-phosphatidyl inositol antibody positivity","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"18b31042633b2fd9bd193541150f16d628aaf3b9a86cab1c12323e500d3335d9","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004420","is_excluded":false,"label":"Arterial thrombosis","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"225f08bcef524c4e541ebf8ef584210f284b2507605182b86c7ff6fed6da2a12","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0010885","is_excluded":false,"label":"Avascular necrosis","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"283c697a68105336b17018ba1192e932b8729540837f383b25fc3bde03656d87","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000707","is_excluded":false,"label":"Abnormality of the nervous system","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2a29d0512c686ecc51a71519381f895e320b6b45a97c218c7974fd590ba9dad3","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0034084","is_excluded":false,"label":"Anti-phosphatidyl ethanolamine antibody positivity","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"305d15a70c5ef89355f844071490f50769987e3071f9ce21d22446efbf7d3977","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:3000042","is_excluded":false,"label":"Abnormal jugular vein morphology","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3727dc432c667b24d44b31d61e1d98b63245730b7c6a75eb73a19fd2b4a7abdd","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002326","is_excluded":false,"label":"Transient ischemic attack","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"43e1b2c115a7f224f4a4f5c436b8981e231b3331fc589a1da6365abe31bfc592","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100576","is_excluded":false,"label":"Amaurosis fugax","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"46c71b7e07a2806578bab8166f35deca793ec5cf504dd1a1a38046f94d2e2485","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001937","is_excluded":false,"label":"Microangiopathic hemolytic anemia","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4d3150ac35c5211964a669e0e2126d58db86481ab469dced97b1eb9d4224eee2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002076","is_excluded":false,"label":"Migraine","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"504207367de964181bf31dedf7b99f9dade27240ca8673f6a8b02f2904de21fd","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001369","is_excluded":false,"label":"Arthritis","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"522ea893cace600ae9309a7b60b232707d7b1daaccd8fb595aa5aa37dca1ebb1","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002638","is_excluded":false,"label":"Superficial thrombophlebitis","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5442f461ac0a7caa30e130beacdd8805c653d9da5a0263c7244afa9e0bbb5467","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0020137","is_excluded":false,"label":"Anticardiolipin IgM antibody positivity","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5556723b5d06b0f233a0f96b2642df9b652cc6a4b7eb0f78a16160cac1f714f4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000726","is_excluded":false,"label":"Dementia","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5ba939de4f33717e9f6dc55b6149df2f584cc0b99169b71a0428c04df9528e2b","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001297","is_excluded":false,"label":"Stroke","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"60d3a89acaf63107afcd2469f02fc54e2d5e267db94a6cfa8b19dec2ea8e1122","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002625","is_excluded":false,"label":"Deep venous thrombosis","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"680d82575f7475c0fd581f8a1aaff052d98c91cefcf6f0a96a70e258d37eec2f","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004844","is_excluded":false,"label":"Coombs-positive hemolytic anemia","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"701f5f6893cab8037817484e62ed392a1a9d4a1698e84bec481f3b0e74f6b168","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0034100","is_excluded":false,"label":"Anti-phosphatidyl serine antibody positivity","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"789377788c8d20dd3b40b329e776627651d840706b2ef0490e84f617405eda8c","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0100758","is_excluded":false,"label":"Gangrene","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"906a89df2604c322f8b068399404fbf91a15471e246e373bde0d17aa3f00135b","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000965","is_excluded":false,"label":"Cutis marmorata","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9f7673fac51bf4749a8efd64ade11f3488579769cc3e4f7fa029ba771d4d3e0f","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0020136","is_excluded":false,"label":"Anticardiolipin IgG antibody positivity","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a03bcacef923d748df04c7977ada38ca428a67d5dba24ee411b1e0fe1753410d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a2c1d6f492fa1541ba857803d4e376a096d0f23a7497e1cb155883ef02fa5a33","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002829","is_excluded":false,"label":"Arthralgia","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a4f3e588d6cba0d81500875aa1d4a7d670466a82c974769829b708ee741a43ee","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0200042","is_excluded":false,"label":"Skin ulcer","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a9d3899033e7ae92496b2faefedf139c86e0f62d4378fecea9b6f1bdd5a29f92","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001654","is_excluded":false,"label":"Abnormal heart valve morphology","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b881ae971fc780685e0544a904e9ab2ff3e04de729dd52ee7250e73f78ccab7f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0006846","is_excluded":false,"label":"Acute encephalopathy","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bae367b7c72ce1e06be068e2f22bc265a562712c26468d5237627ce0340511ab","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0034097","is_excluded":false,"label":"Anti-phosphatidyl choline antibody positivity","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bcee1701ee81c9d78cf4b297cc6ab09a36e4fc5972b2a6eec099efe41c7115ff","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004936","is_excluded":false,"label":"Venous thrombosis","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bff21dbfba9b691ab65b43298db462f1dba0a12d03052d517c3a88e05164236d","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0034098","is_excluded":false,"label":"Anti-phosphatidyl glycerol antibody positivity","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c24fa480d710f257c3d90b128a618e071070fa01d1397fa670714ee7db4100a5","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002641","is_excluded":false,"label":"Peripheral thrombosis","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c3dcc39f2c476ae52c7b01dc105a8b144e13ddd468a4d529841731f71fe196a9","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c772651f688cc5000459659e06d0340943bd84b7d25d6d47114d3399a347804a","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002204","is_excluded":false,"label":"Pulmonary embolism","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c9f1499bfcb635eead7b098888f9f6f021e9b36d1293244767d3a682f483cd7e","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001658","is_excluded":false,"label":"Myocardial infarction","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cd453599b6dc819b82c5e26db8acf470f074ff8a138e79189c1337fee8b1a034","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0003613","is_excluded":false,"label":"Antiphospholipid antibody positivity","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ce9bfbd9d0a46996e1352907d4173e52d09dfac1ccb6490ea98ea442a22fa74d","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031653","is_excluded":false,"label":"Abnormal heart valve physiology","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dd182683b3dc33bb4a22e6ef95ce17cddc79d523e54ac10787ffebeeeff5f26e","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001681","is_excluded":false,"label":"Angina pectoris","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dd40f356faaad82fd0ee763ebf32e0fcc7aeaafc2eb8d0203582cda2bba0bbf7","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0032376","is_excluded":false,"label":"Anti-beta 2 glycoprotein I antibody positivity","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ddc09f4e8edc2073085f5f42c4e77da9eec736cd08035c5688f5bc1ecd703ac3","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0025324","is_excluded":false,"label":"Arterial occlusion","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"eb1b8a15eafbb9ee65d6edef61ddfddf8b344b22862344bb85253f4028eec99a","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0005244","is_excluded":false,"label":"Gastrointestinal infarctions","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ecd8cce8e8802d5d5b97e75007876d46920bdd059efdb23f351341f5c810612c","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011112","is_excluded":false,"label":"Abnormal circulating cytokine concentration","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f872f9aae28fc7ec2882c6b427417767828dee713cd374131155d451dc70e3c5","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002092","is_excluded":false,"label":"Pulmonary arterial hypertension","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f8821c962e2cadce4450f184ee25a8baed1d46b0056c04242bd03616c9235de8","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0025326","is_excluded":false,"label":"Retinal arterial occlusion","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fcaed1d25322aa6bf2da61fa97ba6ffd4d3460062e82c98e4acaf502a4a7c793","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0034101","is_excluded":false,"label":"Anti-annexin-V antibody positivity","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fe3011f4464e5625eaa9855587a8a32bace175043a074d9ae98c66575aa1d12b","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0012819","is_excluded":false,"label":"Myocarditis","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ff9642381671e05b3e0a40e01952e3a9db7bc710cb6ef49f9734dbf7ccdb66fa","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:464343","disease_name":"Catastrophic antiphospholipid syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002072","is_excluded":false,"label":"Chorea","onset_id":null,"reference":"ORPHA:464343","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9820\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0009820</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare systemic autoimmune disease characterized by acute onset of life-threatening thromboses in three or more organs either simultaneously or within less than a week, in the presence of serum antiphospholipid antibodies (such as lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein 1 antibodies), and with histopathological confirmation of small-vessel occlusion in at least one affected organ. The condition is often precipitated by infection, trauma, or surgery.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9820\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"catastrophic-antiphospholipid","sourceDocuments":[{"name":"GARD: Catastrophic antiphospholipid syndrome","reviewed":null,"source_release":"2026-10-25T03:40:48Z","url":"https://rarediseases.info.nih.gov/diseases/9820"}],"sourceNote":"","synonyms":["CAPS","caps","catastrophic APS"],"takeawayHtml":"","title":"catastrophic antiphospholipid syndrome"},"schemaVersion":1}
